In a patient with an indwelling Foley catheter who has budding yeast and hyphae on urine microscopy, what is the appropriate management?

Management of Candiduria in Patients with Indwelling Foley Catheters

Remove the Foley catheter if at all feasible—this is the single most important intervention and often sufficient to clear candiduria without antifungal therapy in asymptomatic patients. 1

Initial Assessment: Colonization vs. Infection

The presence of budding yeast and hyphae in urine from a catheterized patient almost always represents colonization rather than true infection, particularly if the patient is asymptomatic 1. The key clinical decision is determining whether antifungal treatment is actually needed.

When NOT to Treat (Most Common Scenario)

Do not initiate antifungal therapy if the patient is asymptomatic—candiduria in this setting is colonization and does not require treatment 1. Multiple studies demonstrate that:

• Candiduria does not commonly lead to candidemia 1
• Treatment does not reduce mortality in asymptomatic patients 1
• Candiduria is a marker of illness severity, not a cause of death 1

Simply removing the catheter clears candiduria in approximately 50% of asymptomatic patients without any antifungal therapy 2, 3.

When TO Treat (Specific High-Risk Situations)

Initiate antifungal therapy only in these specific circumstances:

1. Symptomatic cystitis or pyelonephritis: Fever, dysuria, suprapubic pain, flank pain, or costovertebral angle tenderness 1

2. Planned urologic instrumentation or surgery: High risk of candidemia with manipulation 1

3. Neutropenic patients with fever and candiduria: May indicate invasive candidiasis, though recent evidence suggests even this may not require treatment 1

4. Neonates with very low birth weight: High risk for invasive candidiasis 1

5. Urinary tract obstruction present: Requires both antifungal therapy and relief of obstruction 1

Treatment Algorithm (When Treatment is Indicated)

Step 1: Remove or Replace the Catheter

This is mandatory and strongly recommended 1. Obtain urine culture ideally after catheter replacement for accurate microbiology 4.

Step 2: Species-Directed Antifungal Therapy

For fluconazole-susceptible organisms (most C. albicans):

• Oral fluconazole 200 mg (3 mg/kg) daily for 2 weeks for cystitis 1
• Oral fluconazole 200-400 mg (3-6 mg/kg) daily for 2 weeks for pyelonephritis 1
• Fluconazole is the drug of choice because it achieves high urinary concentrations and is available orally 1, 2, 3

For fluconazole-resistant C. glabrata:

• Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1
• OR Oral flucytosine 25 mg/kg four times daily for 7-10 days (cystitis) or 2 weeks (pyelonephritis) 1
• Amphotericin B bladder irrigation (50 mg/L sterile water daily for 5 days) may be considered for resistant cystitis 1

For C. krusei:

• Amphotericin B deoxycholate 0.3-0.6 mg/kg daily for 1-7 days 1

Step 3: Address Underlying Risk Factors

• Discontinue or modify antibiotics if possible 5
• Optimize glycemic control in diabetic patients 1, 6
• Ensure adequate urinary drainage 6
• Consider daily bladder irrigation in complicated cases 6

Critical Pitfalls to Avoid

1. Do not treat asymptomatic candiduria routinely—this is the most common error in clinical practice 7, 8. Studies show 60% of clinicians inappropriately treat asymptomatic candiduria 8, and approximately 31% of antifungal therapy for candiduria is unnecessary 9.

2. Do not use echinocandins or azoles other than fluconazole for urinary tract infections—they achieve inadequate urinary concentrations and are ineffective 1, 2, 3

3. Do not rely on colony counts or pyuria to differentiate colonization from infection in catheterized patients—these parameters are unreliable 1, 3

4. Do not forget to remove the catheter—this is never attempted in many cases despite being the most effective intervention 8

5. Do not assume treatment prevents candidemia—it does not change mortality rates in asymptomatic patients 1

Special Considerations

Fungus balls or renal abscesses: If imaging reveals fungal masses causing obstruction, antifungal therapy alone is insufficient—percutaneous drainage or endoscopic intervention is required 1, 10, 6.

Persistent symptoms despite therapy: Consider adding adjunctive therapy (e.g., caspofungin with fluconazole), intensifying source control measures, and ensuring adequate drainage 6.